Status:
COMPLETED
Stellate Ganglion Block Can Cause Enhanced Recovery After Coronary Arteries Bypass Grafting Surgery
Lead Sponsor:
wail abdelaal
Collaborating Sponsors:
Ain Shams University
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The effects of SGB on the cardiovascular system remain controversial since the cardiac sympathetic nerves pass through the stellate ganglion. SGB is expected to have an ameliorative effect on impaired...
Detailed Description
investigators chose left SGB being safer with regards conductivity changes when compared to right SGB, in the present study investigators are trying to examine and compare whether coronary reperfusion...
Eligibility Criteria
Inclusion
- Ischemic heart disease patients age above 18 years
Exclusion
- allergy to LA, severe COPD
Key Trial Info
Start Date :
January 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04439058
Start Date
January 22 2020
End Date
June 1 2020
Last Update
June 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wail Abdelaal
Cairo, Egypt, 00202